AURORA CANNABIS INC (ACB) Stock Price & Overview

NASDAQ:ACBCA05156X8504

Current stock price

3.44 USD
+0.09 (+2.69%)
At close:
3.42 USD
-0.02 (-0.58%)
After Hours:

The current stock price of ACB is 3.44 USD. Today ACB is up by 2.69%. In the past month the price decreased by -1.71%. In the past year, price decreased by -14.32%.

ACB Key Statistics

52-Week Range3.07 - 6.665
Current ACB stock price positioned within its 52-week range.
1-Month Range3.07 - 3.66
Current ACB stock price positioned within its 1-month range.
Market Cap
195.082M
P/E
N/A
Fwd P/E
59.22
EPS (TTM)
-0.65
Dividend Yield
N/A

ACB Stock Performance

Today
+2.69%
1 Week
+2.99%
1 Month
-1.71%
3 Months
-20.74%
Longer-term
6 Months -39.12%
1 Year -14.32%
2 Years -62.73%
3 Years -42.67%
5 Years -96.15%
10 Years N/A

ACB Stock Chart

AURORA CANNABIS INC / ACB Daily stock chart

ACB Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to ACB. When comparing the yearly performance of all stocks, ACB is a bad performer in the overall market: 84.53% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

ACB Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to ACB. ACB may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ACB Earnings

On February 4, 2026 ACB reported an EPS of 0.03 and a revenue of 94.19M. The company missed EPS expectations (-86.02% surprise) and beat revenue expectations (0.96% surprise).

Next Earnings DateJun 16, 2026
Last Earnings DateFeb 4, 2026
PeriodQ3 / 2026
EPS ReportedCA$0.03
Revenue Reported94.191M
EPS Surprise -86.02%
Revenue Surprise 0.96%

ACB Forecast & Estimates

10 analysts have analysed ACB and the average price target is 5.2 USD. This implies a price increase of 51.15% is expected in the next year compared to the current price of 3.44.

For the next year, analysts expect an EPS growth of -2438.15% and a revenue growth 6.2% for ACB


Analysts
Analysts74
Price Target5.2 (51.16%)
EPS Next Y-2438.15%
Revenue Next Year6.2%

ACB Groups

Sector & Classification

Sub-Industry
Pharmaceuticals
Index Membership

ACB Financial Highlights

Over the last trailing twelve months ACB reported a non-GAAP Earnings per Share(EPS) of -0.65. The EPS decreased by -502.65% compared to the year before.


Income Statements
Revenue(TTM)373.12M
Net Income(TTM)-88.74M
Industry RankSector Rank
PM (TTM) N/A
ROA -11.45%
ROE -16.55%
Debt/Equity 0.06
Chartmill High Growth Momentum
EPS Q2Q%-94.83%
Sales Q2Q%6.79%
EPS 1Y (TTM)-502.65%
Revenue 1Y (TTM)16.54%

ACB Ownership

Ownership
Inst Owners13.02%
Shares56.71M
Float56.68M
Ins Owners0.04%
Short Float %12.88%
Short Ratio8.42

About ACB

Company Profile

ACB logo image Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. The company is headquartered in Leduc, Alberta and currently employs 1,101 full-time employees. The company went IPO on 2007-09-26. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally. The Company’s segments include Cannabis and Plant Propagation. The firm's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, IndiMed and CraftPlant. The firm also holds a 50.1% controlling interest in Bevo Farms Ltd., a supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.

Company Info

IPO: 2007-09-26

AURORA CANNABIS INC

2207 90B Street Sw

Leduc ALBERTA T5J 1Y6 CA

CEO: Terry Booth

Employees: 1101

ACB Company Website

ACB Investor Relations

Phone: 16043625207

AURORA CANNABIS INC / ACB FAQ

Can you describe the business of AURORA CANNABIS INC?

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. The company is headquartered in Leduc, Alberta and currently employs 1,101 full-time employees. The company went IPO on 2007-09-26. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally. The Company’s segments include Cannabis and Plant Propagation. The firm's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, IndiMed and CraftPlant. The firm also holds a 50.1% controlling interest in Bevo Farms Ltd., a supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.


What is the stock price of AURORA CANNABIS INC today?

The current stock price of ACB is 3.44 USD. The price increased by 2.69% in the last trading session.


Does AURORA CANNABIS INC pay dividends?

ACB does not pay a dividend.


How is the ChartMill rating for AURORA CANNABIS INC?

ACB has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


How is the valuation of AURORA CANNABIS INC (ACB) based on its PE ratio?

AURORA CANNABIS INC (ACB) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.65).


Is AURORA CANNABIS INC (ACB) stock a good buy?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ACB.


What is the market capitalization of ACB stock?

AURORA CANNABIS INC (ACB) has a market capitalization of 195.08M USD. This makes ACB a Micro Cap stock.